Healthy Extracts (HYEX) Capital Expenditures (2019 - 2022)

Healthy Extracts (HYEX) posted quarterly Capital Expenditures of $7987.0 for Q1 2022, down 65.25% quarter-over-quarter from $22985.0 in Q1 2019.

Healthy Extracts (HYEX) Capital Expenditures (2019 - 2022) Analysis & Trends

Healthy Extracts' Capital Expenditures history runs 2 years deep, the most recent figure standing at $7987.0 for Q1 2022.

In Q1 2022, Capital Expenditures changed N/A year-over-year to $7987.0; the TTM figure through Dec 2022 stood at $7987.0 (changed N/A YoY), while the FY2025 annual figure was $19302.0, changed N/A from the prior year.
Capital Expenditures for Q1 2022 stood at $7987.0, down from $22985.0 in the prior quarter.
The five-year high for Capital Expenditures was $22985.0 in Q1 2019, with the low at $7987.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	104.00 Mn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	117.00 Mn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-337.60 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	108.00 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	52.80 Mn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	7.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	33.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Healthy Extracts	19.90 Mn	19.71 Mn	1.45 Mn	-

Download Data